Biomimetic nanocarriers replicate natural biological components (e.g., cell membrane coatings, RBC-mimicking structures, platelet-inspired designs) to improve drug stability, targeted release, immune evasion, and site-specific delivery. They address limitations of traditional nanocarriers by enhancing biocompatibility and functionality. The market is driven by rising chronic disease burdens and...

"Executive Summary Biomimetic Nanocarrier Drug Market Trends: Share, Size, and Future Forecast  The global biomimetic nanocarrier drug market size was valued at USD 42.12 million in 2024 and is expected to reach USD 61.28 million by 2032, at a CAGR of 4.80% during the forecast period Keeping into consideration the customer requirement, Biomimetic...